APCDD1 was first identified as a direct Wnt target of the β-catenin/TCF4 transcription complex by Takahashi et al. who further reported increased APCDD1 expression in primary colon cancer tissue compared with corresponding healthy tissue [25]. Here, APCDD1 is linked to malignant colon neoplasm.